Cargando…

Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism

Patients with primary aldosteronism (PA) are more susceptible to cardiovascular disease and mortality than patients with primary hypertension. This is mostly attributed to excess production of aldosterone and its effects on the development of vascular injury. A novel functional test (T(50)) measures...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantauskaite, Marta, Bolten, Katharina, Boschheidgen, Matthias, Schmidt, Claudia, Kolb, Thilo, Eckardt, Kai Uwe, Pasch, Andreas, Schimmöller, Lars, Rump, Lars C., Voelkl, Jakob, Stegbauer, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818752/
https://www.ncbi.nlm.nih.gov/pubmed/35141300
http://dx.doi.org/10.3389/fcvm.2022.771096
_version_ 1784645898844766208
author Kantauskaite, Marta
Bolten, Katharina
Boschheidgen, Matthias
Schmidt, Claudia
Kolb, Thilo
Eckardt, Kai Uwe
Pasch, Andreas
Schimmöller, Lars
Rump, Lars C.
Voelkl, Jakob
Stegbauer, Johannes
author_facet Kantauskaite, Marta
Bolten, Katharina
Boschheidgen, Matthias
Schmidt, Claudia
Kolb, Thilo
Eckardt, Kai Uwe
Pasch, Andreas
Schimmöller, Lars
Rump, Lars C.
Voelkl, Jakob
Stegbauer, Johannes
author_sort Kantauskaite, Marta
collection PubMed
description Patients with primary aldosteronism (PA) are more susceptible to cardiovascular disease and mortality than patients with primary hypertension. This is mostly attributed to excess production of aldosterone and its effects on the development of vascular injury. A novel functional test (T(50)) measures serum calcification propensity. Lower T(50)-values predict higher cardiovascular risk. We investigated serum calcification propensity and vascular calcification in PA and resistant hypertension (RH). T(50) measurement was performed in patients with PA (n = 66) and RH (n = 28) at baseline and after 403 (279–640) and 389 (277–527) days of treatment. No significant differences in T(50)-values were observed between the groups (371 ± 65 and 382 ± 44 min, in PA and RH group, respectively, p > 0.05). However, higher aldosterone-to-renin ratios were associated with lower T(50)-values in PA-patients (r −0.282, p < 0.05). Furthermore, lower T(50)-values were associated with increased abdominal aortic calcification measured by Agatston score in PA (r −0.534, p < 0.05). In both, PA and RH, higher atherosclerotic cardiovascular disease (ACSVD) scores (r −0.403, p < 0.05) and lower HDL (r 0.469, p < 0.05) was related to lower T(50)-values in a linear regression model. Adrenalectomy or medical treatment did not increase T(50)-values. In comparison to patients with stable T(50)-values, PA patients with a decrease in T(50) after intervention had higher serum calcium concentrations at baseline (2.24 ± 0.11 vs. 2.37 ± 0.10 mmol/l, p < 0.05). This decline of T(50)-values at follow-up was also associated with a decrease in serum magnesium (−0.03 ± 0.03 mmol/l, p < 0.05) and an increase in phosphate concentrations (0.11 ± 0.11 mmol/l, p < 0.05). Resistant hypertension patients with a decrease in T(50)-values at follow-up had a significantly lower eGFR at baseline. In summary, these data demonstrate an association between a high aldosterone-to-renin ratio and low T(50)-values in PA. Moreover, lower T(50)-values are associated with higher ACSVD scores and more pronounced vascular calcification in PA. Thus, serum calcification propensity may be a novel modifiable risk factor in PA.
format Online
Article
Text
id pubmed-8818752
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88187522022-02-08 Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism Kantauskaite, Marta Bolten, Katharina Boschheidgen, Matthias Schmidt, Claudia Kolb, Thilo Eckardt, Kai Uwe Pasch, Andreas Schimmöller, Lars Rump, Lars C. Voelkl, Jakob Stegbauer, Johannes Front Cardiovasc Med Cardiovascular Medicine Patients with primary aldosteronism (PA) are more susceptible to cardiovascular disease and mortality than patients with primary hypertension. This is mostly attributed to excess production of aldosterone and its effects on the development of vascular injury. A novel functional test (T(50)) measures serum calcification propensity. Lower T(50)-values predict higher cardiovascular risk. We investigated serum calcification propensity and vascular calcification in PA and resistant hypertension (RH). T(50) measurement was performed in patients with PA (n = 66) and RH (n = 28) at baseline and after 403 (279–640) and 389 (277–527) days of treatment. No significant differences in T(50)-values were observed between the groups (371 ± 65 and 382 ± 44 min, in PA and RH group, respectively, p > 0.05). However, higher aldosterone-to-renin ratios were associated with lower T(50)-values in PA-patients (r −0.282, p < 0.05). Furthermore, lower T(50)-values were associated with increased abdominal aortic calcification measured by Agatston score in PA (r −0.534, p < 0.05). In both, PA and RH, higher atherosclerotic cardiovascular disease (ACSVD) scores (r −0.403, p < 0.05) and lower HDL (r 0.469, p < 0.05) was related to lower T(50)-values in a linear regression model. Adrenalectomy or medical treatment did not increase T(50)-values. In comparison to patients with stable T(50)-values, PA patients with a decrease in T(50) after intervention had higher serum calcium concentrations at baseline (2.24 ± 0.11 vs. 2.37 ± 0.10 mmol/l, p < 0.05). This decline of T(50)-values at follow-up was also associated with a decrease in serum magnesium (−0.03 ± 0.03 mmol/l, p < 0.05) and an increase in phosphate concentrations (0.11 ± 0.11 mmol/l, p < 0.05). Resistant hypertension patients with a decrease in T(50)-values at follow-up had a significantly lower eGFR at baseline. In summary, these data demonstrate an association between a high aldosterone-to-renin ratio and low T(50)-values in PA. Moreover, lower T(50)-values are associated with higher ACSVD scores and more pronounced vascular calcification in PA. Thus, serum calcification propensity may be a novel modifiable risk factor in PA. Frontiers Media S.A. 2022-01-24 /pmc/articles/PMC8818752/ /pubmed/35141300 http://dx.doi.org/10.3389/fcvm.2022.771096 Text en Copyright © 2022 Kantauskaite, Bolten, Boschheidgen, Schmidt, Kolb, Eckardt, Pasch, Schimmöller, Rump, Voelkl and Stegbauer. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Kantauskaite, Marta
Bolten, Katharina
Boschheidgen, Matthias
Schmidt, Claudia
Kolb, Thilo
Eckardt, Kai Uwe
Pasch, Andreas
Schimmöller, Lars
Rump, Lars C.
Voelkl, Jakob
Stegbauer, Johannes
Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism
title Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism
title_full Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism
title_fullStr Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism
title_full_unstemmed Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism
title_short Serum Calcification Propensity and Calcification of the Abdominal Aorta in Patients With Primary Aldosteronism
title_sort serum calcification propensity and calcification of the abdominal aorta in patients with primary aldosteronism
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818752/
https://www.ncbi.nlm.nih.gov/pubmed/35141300
http://dx.doi.org/10.3389/fcvm.2022.771096
work_keys_str_mv AT kantauskaitemarta serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT boltenkatharina serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT boschheidgenmatthias serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT schmidtclaudia serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT kolbthilo serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT eckardtkaiuwe serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT paschandreas serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT schimmollerlars serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT rumplarsc serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT voelkljakob serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism
AT stegbauerjohannes serumcalcificationpropensityandcalcificationoftheabdominalaortainpatientswithprimaryaldosteronism